GALEN founder Allen McClay’s personal spending spree on acquiring company assets rose to €277m yesterday when he spent €34m buying Galen’s Pharmaceutical Development and Manufacturing Services business (PDMS).

Galen Holdings, the Northern Ireland holding company for a host of pharmaceutical companies, has sold its Pharmaceutical Development and Manufacturing Services business (PDMS) for £20m (€28.70m).